Status:
COMPLETED
Research of Circulating Tumor Cells Released During Endometrial Cancer Surgery.
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Endometrial Cancer
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to investigate the spread of Circulating Tumor Cells (CTC) during surgery in endometrial cancer. Although this cancer is often discovered at early stage, the risk of recur...
Detailed Description
The goal of this single-center clinical trial is to determine the best blood punction site to observe the spreading of CTC during surgery in endometrial cancer. CTCs are very rare events on blood and ...
Eligibility Criteria
Inclusion
- Patients with endometrial cancer
- Being affiliated or benefiting from a French social security system
Exclusion
- Patients with an other cancer
Key Trial Info
Start Date :
September 16 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 16 2021
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT04021459
Start Date
September 16 2019
End Date
September 16 2021
Last Update
October 3 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Montpellier University Hospital
Montpellier, France, 34295
2
CHU de Nîmes
Nîmes, France, 30029